ATP Antagonizes Thrombin-Induced Signal Transduction through 12(S)-HETE and cAMP

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Burzaco, Jaione ^a   Conde, Manuel ^a   Parada, Luis A ^b   Zugaza, José L ^a,c,d   Dehaye, Jean Paul ^e   Marino, Aida ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

^c ACHUCARRO BASQUE CENTER FOR NEUROSCIENCE   (Spain)

^d BASQUE FOUNDATION FOR SCIENCE   (Spain)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; APYRASE; CALCIUM ION; CYCLIC AMP; INOSITOL PHOSPHATE; INOSITOL PHOSPHATE 1; INOSITOL PHOSPHATE 2; INOSITOL PHOSPHATE 3; LIPOXYGENASE INHIBITOR; MAGNESIUM; NORDIHYDROGUARETIC ACID; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INHIBITION KINETICS; SECOND MESSENGER; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; APYRASE; ARACHIDONATE 12-LIPOXYGENASE; CALCIUM SIGNALING; CYCLIC AMP; HUMANS; MAGNESIUM; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y1; RECEPTORS, PURINERGIC P2Y12; SIGNAL TRANSDUCTION; THROMBIN; TIME FACTORS;

EID: 84879485504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067117     Document Type: Article

References (67)

1. Shankar H, Kahner B, Kunapuli SP, (2006) G-protein dependent platelet signaling-perspectives for therapy. Curr Drug Targets 7: 1253-1263.
2. Zhou L, Schmaier AH, (2005) Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 123: 172-183.
3. Lechtenberg BC, Freund SM, Huntington JA, (2009) An ensemble view of thrombin allostery. Biol Chem 393: 889-898.
4. Coughlin SR, (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3: 1800-1814.
5. Stalker TJ, Newman DK, Ma P, Wannemacher KM, Brass LF (2012) Platelet signaling. Handb Exp Pharmacol: 59-85.
6. Hechler B, Gachet C, (2011) P2 receptors and platelet function. Purinergic Signal 7: 9247-9256.
7. Garcia AE, Mada SR, Rico MC, Dela Cadena RA, Kunapuli SP, (2011) Clopidogrel, a P2Y12 Receptor Antagonist, Potentiates the Inflammatory Response in a Rat Model of Peptidoglycan Polysaccharide-Induced Arthritis. PLoS One 6: e26035.
8. Jackson SP, Yap CL, Anderson KE, (2004) Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 32: 387-392.
9. Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, et al. (2006) Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 108: 3045-3052.
10. Schoenwaelder S, Ono A, Sturgeon S, Chan SM, Mangin P, et al. (2007) Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets. J Biol Chem 282: 28648-28658.
11. Gratacap MP, Guillermet-Guibert J, Martin V, Chicanne G, Tronchere H, et al. (2011) Regulation and roles of PI3Kbeta, a major actor in platelet signaling and functions. Adv Enzyme Regul 51: 106-116.
12. Murugappa S, Kunapuli SP, (2006) The role of ADP receptors in platelet function. Front Biosci 11: 1977-1986.
13. Grandt R, Aktories K, Jakobs KH, (1986) Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochem J 237: 669-674.
14. Vaidyula VR, Rao AK, (2003) Role of Galphaq and phospholipase C-beta2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Gαq and phospholipase C-ß2. Br J Haematol 121: 491-496.
15. Adam F, BVerbeuren T, Fauchere J, Guillin M, Jandrot-Perrus M, (2003) Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP. J Thromb Haemost 1: 798-804.
16. Nylander S, Mattsson C, (2003) Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action. Blood Coagul Fibrinolysis 14: 159-167.
17. van Giezen JJ, Sidaway J, Glaves P, Kirk I, Bjorkman JA, (2012) Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. J Cardiovasc Pharmacol Ther 17: 164-172.
18. Stafford NP, Pink AE, White AE, Glenn JR, Heptinstall S, (2003) Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 23: 1928-1933.
19. Hourani SM, Cusack NJ, (1991) Pharmacological receptors on blood platelets. Pharmacol Rev 43: 243-298.
20. Hechler B, Magnenat S, Zighetti ML, Kassack MU, Ullmann H, et al. (2005) Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4′,4′′,4′′′-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]. J Pharmacol Exp Ther 314: 232-243.
21. Mahaut-Smith MP, Tolhurst G, Evans RJ, (2004) Emerging roles for P2X1 receptors in platelet activation. Platelets 15: 131-144.
22. Oury C, Toth-Zsamboki E, Thys C, Tytgat J, Vermylen J, et al. (2001) The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 86: 1264-1271.
23. Krishnamurthi S, Patel Y, Kakkar VV, (1988) Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5′-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction. Biochem J 250: 209-214.
24. Dragan YP, Ellis EF, (1990) Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets. Biochem Pharmacol 39: 27-32.
25. Azula FJ, Alonso R, Marino A, Trueba M, Macarulla JM, (1993) Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets. Am J Physiol 265: C1681-1688.
26. Azula FJ, Alzola ES, Conde M, Trueba M, Macarulla JM, et al. (1996) Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside. Mol Pharmacol 50: 367-379.
27. Grynkiewicz G, Poenie M, Tsien RY, (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
28. Haslam RJ, Dickinson NT, Jang EK, (1999) Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 82: 412-423.
29. Alexander S (1995) The measurements of cycle AMP levels in biological preparations. Signal Transduction Protocols (eds, KendallDA &Hill SJ) Human Press Inc., Totowa, NJ: 63-78.
30. Marcondes S, Cardoso MH, Morganti RP, Thomazzi SM, Lilla S, et al. (2006) Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration. Proc Natl Acad Sci U S A 103: 3434-3439.
31. Kim S, Foster C, Lecchi A, Quinton TM, Prosser DM, et al. (2002) Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 99: 3629-3636.
32. Morita I, Murota S, (1987) Role of 12-lipoxygenase products of arachidonic acid on platelet aggregation. Adv Prostaglandin Thromboxane Leukot Res 17A: 219-223.
33. Calzada C, Vericel E, Lagarde M, (1997) Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J 325 (Pt 2): 495-500.
34. Dubyak GR, El-Moatassim C, (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265: C577-606.
35. McNicol A, Israels SJ, (1999) Platelet dense granules: structure, function and implications for haemostasis. Thromb Res 95: 1-18.
36. Beigi R, Kobatake E, Aizawa M, Dubyak GR, (1999) Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol Cell Physiol 276: 267-278.
37. Corriden R, Insel PA, Junger WG, (2007) A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells. Am J Physiol Cell Physiol 293: C1420-1425.
38. Gordon JL, (1986) Extracellular ATP: effects, sources and fate. Biochem J 233: 309-319.
39. McMillian MK, Soltoff SP, Cantley LC, Rudel R, Talamo BR, (1993) Two distinct cytosolic calcium responses to extracellular ATP in rat parotid acinar cells. Br J Pharmacol 108: 453-461.
40. Alzola E, Perez-Etxebarria A, Kabre E, Fogarty DJ, Metioui M, et al. (1998) Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. J Biol Chem 273: 30208-30217.
41. Fabiato A, (1988) Computer programs for calculating total from specified free or free specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods in Enzymology 157: 378-417.
42. Bursnstock G, (2012) Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Bioessays 34: 218-225.
43. Chambers DA, Salzman EW, Neri LL, (1967) Characterization of "ecto-ATPase" of human blood platelets. Arch Biochem Biophys 119: 173-178.
44. Soslau G, McKenzie RJ, Brodsky I, Devlin TM, (1995) Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets. Biochim Biophys Acta 1268: 73-80.
45. Soslau G, Youngprapakorn D, (1997) A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochimica et Biophysica Acta 1355: 131-140.
46. Metioui M, Amsallem H, Alzola E, Chaib N, Elyamani A, et al. (1996) Low affinity purinergic receptor modulates the response of rat submandibular glands to carbachol and substance P. J Cell Physiol. 168: 462-475.
47. Grenegård M, Vretenbrant-Oberg K, Nylander M, Désilets S, Lindström EG, et al. (2008) The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine. J Biol Chem 283: 18493-18504.
48. Erhardt JA, Toomey JR, Douglas SA, Johns DG, (2006) P2X1 stimulation promotes thrombin receptor-mediated platelet aggregation. J Thromb Haemost 4: 882-890.
49. Fung CY, Cendana C, Farndale RW, Mahaut-Smith MP, (2007) Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet. J Thromb Haemost 5: 910-917.
50. Rolf MG, Brearley CA, Mahaut-Smith MP, (2001) Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP. Thromb Haemost 85: 303-308.
51. North RA, Jarvis MF, (2012) P2X Receptors as Drug Targets. Mol Pharmacol 83: 759-769.
52. Cauwenberghs S, Feijge MA, Hageman G, Hoylaerts M, Akkerman JW, et al. (2006) Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation. Transfusion 46: 1018-1028.
53. Maurice DH, Haslam RJ, (1990) Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37: 671-681.
54. Smolenski A, (2012) Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost 10: 167-176.
55. Soslau G, Brodsky I, Parker J, (1993) Occupancy of P2 purinoceptors with unique properties modulates the function of human platelets. Biochim Biophys Acta 1177: 199-207.
56. Eigenthaler M, Nolte C, Halbrugge M, Walter U, (1992) Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem 205: 471-481.
57. Seiler S, Gillespie E, Arnold AJ, Brassard CL, Meanwell NA, et al. (1991) Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets. Thromb Res 62: 31-42.
58. Gachet C, (2005) The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Ther 108: 180-192.
59. Ishii-Watabe A, Uchida E, Mizuguchi H, Hayakawa T, (2000) On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP. Biochem Pharmacol 59: 1345-1355.
60. Leon C, Hechler B, Freund M, Eckly A, Vial C, et al. (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104: 1731-1737.
61. Riendeau D, Guay J, Weech PK, Laliberte F, Yergey J, et al. (1994) Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 269: 15619-15624.
62. Gonzalez-Nunez D, Claria J, Rivera F, Poch E, (2001) Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 37: 334-338.
63. Kaur G, Jalagadugula G, Mao G, Rao AK, (2010) RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency. Blood 115: 3128-3135.
64. Samuelsson B, (2012) Role of basic science in the development of new medicines: examples from the eicosanoid field. J Biol Chem 287: 10070-10080.
65. Zoccarato F, Ruzzene M, Cavallini L, Doni MG, Francesconi MA, et al. (1991) Platelet responses promoted by the activation of protein kinase C or the increase of cytosolic Ca2+ are potentiated by adrenaline. Effects of cAMP and staurosporine. Biochim Biophys Acta 1092: 72-78.
66. Johnson EN, Brass LF, Funk CD, (1998) Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase. Proc Natl Acad Sci U S A 95: 3100-3105.
67. Nigam S, Zafiriou MP, (2005) Hepoxilin A3 synthase. Biochem Biophys Res Commun 338: 161-168.